Screening for Major Diseases-Does it Help? 10th Cutter Symposium, May 15, 2026

Value of the Information & Strength of the Argument

The value of the information is high, as it synthesizes decades of research on colorectal cancer screening, including landmark trials and observational studies. The argumentation is solid, with speakers carefully distinguishing between intention-to-screen and per-protocol analyses, and acknowledging limitations such as low uptake rates. The use of modeling to project long-term benefits is a valuable addition. The speakers are credible experts, and the content is well-structured and clear.

The title accurately reflects the content: a symposium on screening for major diseases, with presentations on colorectal and prostate cancer screening.

8/10

The symposium features three eminent epidemiologists from leading institutions (Heidelberg, Harvard) presenting evidence-based reviews of screening for colorectal and prostate cancer. The content is grounded in randomized trials and observational studies, with appropriate caveats about limitations. However, as a symposium, it is primarily expert opinion and review, not original research.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Albert Hofman, welcoming attendees and introducing the Cutter Symposium.
• 02:00Hermann Brenner begins his presentation on colorectal cancer screening, introducing the global burden.
• 10:00Brenner discusses stool tests, including the Minnesota trial and FIT tests.
• 20:00Brenner reviews flexible sigmoidoscopy trials, including the UK trial and its long-term results.
• 30:00Brenner presents the National Polyp Study and evidence for colonoscopy effectiveness.
• 40:00Brenner discusses the Nordic randomized trial of colonoscopy, including intention-to-screen and per-protocol analyses.
• 50:00Brenner presents modeling results for screening strategies in Germany.
• 1:00:00Brenner concludes with summary and implications for screening programs.
• 1:10:00Albert Hofman introduces Lorelei Mucci for her presentation on prostate cancer screening.

• Harvard Chan School of Public Health - Epidemiology Degree Program — Provided in the video description as a resource for degree programs.

• US Preventive Services Task Force recommendations on colorectal cancer screening — Aligns with the symposium's emphasis on screening effectiveness.

• Potential harms of screening — The symposium focuses on benefits, but some studies highlight overdiagnosis and complications, which are not extensively discussed.